Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies.

IF 3.4

Diabetes & metabolic syndrome Pub Date : 2019-01-01 Epub Date: 2018-12-05 DOI:10.1016/j.dsx.2018.11.055

Khadijeh Kalan Farmanfarma, Mahmoud Ali Kaykhaei, Hosein Ali Adineh, Mehdi Mohammadi, Soroosh Dabiri, Alireza Ansari-Moghaddam

{"title":"Prevalence of metabolic syndrome in Iran: A meta-analysis of 69 studies.","authors":"Khadijeh Kalan Farmanfarma, Mahmoud Ali Kaykhaei, Hosein Ali Adineh, Mehdi Mohammadi, Soroosh Dabiri, Alireza Ansari-Moghaddam","doi":"10.1016/j.dsx.2018.11.055","DOIUrl":null,"url":null,"abstract":"Aims: Metabolic syndrome increases the risk of chronic diseases including cardiovascular diseases and diabetes. The present study investigated the prevalence of metabolic syndrome in Iran.Materials and methods: Published articles in English and Persian during 2000-2016 identified using keywords of prevalence, metabolic syndrome, and Iran in the following databases: Web of Science, PubMed, Scopus, Google scholar, SID and Magiran. Random effect model used to calculate the pooled estimates. Heterogeneity of studies assessed using Q statistic, and geographical distribution of metabolic syndrome demonstrated via GIS map. Data were analyzed by STATA-11.Results: The overall prevalence of metabolic syndrome was 30.4% (95%CI: 28.3-32.6) with no significant heterogeneity by diagnostic criteria. The lowest frequency was reported in Sistan and Baluchestan Province [18.3% (95% CI: 12.9-25.8)] compared to the highest in Bushehr [57.8% (95% CI: 41.8-80.0)]. It was significantly more prevalent in women [(34.8% (95%CI: 31.2-38.8)] compared to men [25.7% (95%CI: 23.4-28.3)] (P = 0.001)]. A significant increasing trend (P = 0.001) was observed in different age groups, as metabolic syndrome increased from 12.1% (95% CI: 9.37-15.6) in 20-29 years-old age group to 51.7% (95%CI: 47.4-56.4) in the over 60 years-old age group.Conclusions: Approximately one-third of Iranian adults have metabolic syndrome which varied by regions, age and gender. Then, appropriate intervention based on behavioral patterns of inhabitants and local conditions may help to reduce the burden of disease.","PeriodicalId":520602,"journal":{"name":"Diabetes & metabolic syndrome","volume":" ","pages":"792-799"},"PeriodicalIF":3.4000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dsx.2018.11.055","citationCount":"81","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes & metabolic syndrome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.dsx.2018.11.055","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/12/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 81

Abstract

Aims: Metabolic syndrome increases the risk of chronic diseases including cardiovascular diseases and diabetes. The present study investigated the prevalence of metabolic syndrome in Iran.

Materials and methods: Published articles in English and Persian during 2000-2016 identified using keywords of prevalence, metabolic syndrome, and Iran in the following databases: Web of Science, PubMed, Scopus, Google scholar, SID and Magiran. Random effect model used to calculate the pooled estimates. Heterogeneity of studies assessed using Q statistic, and geographical distribution of metabolic syndrome demonstrated via GIS map. Data were analyzed by STATA-11.

Results: The overall prevalence of metabolic syndrome was 30.4% (95%CI: 28.3-32.6) with no significant heterogeneity by diagnostic criteria. The lowest frequency was reported in Sistan and Baluchestan Province [18.3% (95% CI: 12.9-25.8)] compared to the highest in Bushehr [57.8% (95% CI: 41.8-80.0)]. It was significantly more prevalent in women [(34.8% (95%CI: 31.2-38.8)] compared to men [25.7% (95%CI: 23.4-28.3)] (P = 0.001)]. A significant increasing trend (P = 0.001) was observed in different age groups, as metabolic syndrome increased from 12.1% (95% CI: 9.37-15.6) in 20-29 years-old age group to 51.7% (95%CI: 47.4-56.4) in the over 60 years-old age group.

Conclusions: Approximately one-third of Iranian adults have metabolic syndrome which varied by regions, age and gender. Then, appropriate intervention based on behavioral patterns of inhabitants and local conditions may help to reduce the burden of disease.

查看原文本刊更多论文

伊朗代谢综合征患病率:69项研究的荟萃分析

目的:代谢综合征增加了包括心血管疾病和糖尿病在内的慢性疾病的风险。本研究调查了伊朗代谢综合征的患病率。材料和方法:2000-2016年期间以英语和波斯语发表的文章，使用患病率，代谢综合征和伊朗的关键词在以下数据库中进行识别:Web of Science, PubMed, Scopus, Google scholar, SID和Magiran。随机效应模型用于计算汇总估计。使用Q统计量评估研究的异质性，并通过GIS地图显示代谢综合征的地理分布。数据采用STATA-11进行分析。结果:代谢综合征的总患病率为30.4% (95%CI: 28.3-32.6)，诊断标准无显著异质性。锡斯坦和俾路支斯坦省报告的发病率最低[18.3% (95% CI: 12.9-25.8)]，而布什尔省报告的发病率最高[57.8% (95% CI: 41.8-80.0)]。女性患病率[34.8% (95%CI: 31.2-38.8)]明显高于男性[25.7% (95%CI: 23.4-28.3)] (P = 0.001)。不同年龄组代谢综合征发生率均有显著上升趋势(P = 0.001)，20 ~ 29岁年龄组代谢综合征发生率从12.1% (95%CI: 9.37 ~ 15.6)上升至60岁以上年龄组51.7% (95%CI: 47.4 ~ 56.4)。结论:大约三分之一的伊朗成年人患有代谢综合征，这种情况因地区、年龄和性别而异。然后，根据居民的行为模式和当地条件进行适当的干预可能有助于减轻疾病负担。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes & metabolic syndrome

自引率

0.00%

发文量